ARCHIVES

NTP Board Approves Concept For New Mutagenesis Assays

This article is from The Cancer Letter archive.

Vol. 14 No. 01 | January 1, 1988

Download PDF Visit The Full Archive

Related Articles

Consructio Needs Over Next Five Years Total Estimated $696 Million; NCI Share-$132 Million

January 19, 1979

Two Phase II Trials Display Ramucirumab Potential Efficacy

October 26, 2012

Judge Rules FDA Can’t Enforce Pediatric Rule

October 25, 2002

In Brief: NCCS to hold Candlelight Vigil Sept. 25; Moffit Wins Chemistry-Biology Grants

September 17, 1999

Guest Editorial: The Supreme Court Decision on the ACA and What It Can Mean to Oncology

June 29, 2012

FDA developing guidelines for oncology endpoints.

May 7, 2004